Rx Medicare

Australia’s regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today announced highly successful preclinical trial results of its adult stem cells in the treatment of degenerative intervertebral disc disease, the leading cause of low back pain.

Read More…

Related Posts

• $1.7 Million Grant To Study Stem Cells In Intervertebral Discs Of The Spine Received By Jefferson
• Transplanting People’s Own Stem Cells Into Heart Lessens Pain, Improves Ability To Walk
• Your own stem cells can treat heart disease, study suggests
• Three Surgeons In East Texas Are Successfully Integrating A Novel Stem Cell Procedure For Spine Surgeries
• Stem Cells Jumpstart Bone’s Healing Process
• Benefit Of Adipose-Derived Regenerative Cells In Spinal Disc Model Reported By Cytori
• Sickle Cell Pain May Be From Damaged Tissues Or Nerves
• PositiveID Corporation Successfully Completes Phase I Development Of Its Rapid Virus Detection System
• Is Your Back Pain Caused By Herniated Disc? Single Test Can’t Tell
• New Nanoscopic Material Enables Cartilage To Do What It Doesn’t Do Naturally
• New Tools Use Light To Turn Off Brain Cells And Possibly Treat Brain Disorders
• Silencing brain cells with yellow and blue light
• Alternative Swine Flu Vaccination Provided By Insect Cells
• Natural Flu-Fighting Protein In Human Cells Discovered By Scientists
• Outpatient disc treatment gives long-term back pain relief

Tags: asxmsb, cartilage, cells, damaged, disc, intervertebral, limited, mesoblast, proprietary, repairregenerate, stem, successfully

This entry was posted on Sunday, September 13th, 2009 at 2:09 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.